NLS Collaboration

Collaboration - January 20, 2016

Immunovia in new collaboration

Immunovia and the University of Liverpool enter into collaboration to validate early detection blood test for pancreatic cancer in a prospective clinical study. In line with Immunovia´s strategy to deliver the first validated test for early diagnosis of pancreatic cancer, the company announced yesterday that the first European site participating in its prospective clinical study […]

Collaboration - January 15, 2016

Antaros Medical supports SANOFI research in incretin biology

Antaros Medical, has entered into a research agreement with  SANOFI. The project seeks to increase the understanding of the activity of certain incretins and underscores the vital role Antaros Medical plays as a trusted partner to major drug manufacturers. “The Antaros team has an impressive track record in early clinical experimentation and clinical functional imaging. […]

Collaboration - January 13, 2016

AstraZeneca enters two new collaborations

AstraZeneca announce a new collaboration with Moderna Therapeutics  to co-develop and co-commercialise immuno-oncology mRNA therapeutics and a new lung cancer clinical trial collaboration with Incyte. Lung cancer clinical trial collaboration The collaboration with Incyte aims to evaluate the efficacy and safety of Incyte’s Janus-associated kinase (JAK) 1 inhibitor, INCB39110, in combination with AstraZeneca’s epidermal growth factor receptor (EGFR) […]

Collaboration - January 8, 2016

Bavarian Nordic collaborates with Janssen

Janssen Pharmaceuticals has entered into a collaboration and license agreement with Bavarian Nordic to leverage their MVA-BN technology, jointly with Janssen’s own AdVac technology, in the development and commercialization of a heterologous prime-boost vaccine for the treatment of HPV chronic infections which can lead to cancer. Under this agreement, Janssen will conduct all clinical development […]

Collaboration - January 5, 2016

Novo Nordisk enter partnership to improve environment and health

Novo Nordisk and the C40 Cities Climate Leadership Group (C40) have entered a research-based partnership aimed at establishing that green policies in cities are beneficial to both the state of the environment and the health of their citizens. The collaboration aims to generate new insights on a range of co-benefits of climate action, in particular the health […]

Collaboration - October 20, 2015

A1M Pharma enters research collaboration

A1M Pharma has signed a sponsored research collaboration agreement with the Fred Hutchinson Cancer Research Centre in Seattle, USA. The purpose of the collaboration is to elucidate molecular and tissue-specific mechanisms of action of the endogenous protein A1M. Within the frame of the collaboration, the internationally renowned nephrologist and researcher Dr Richard Zager of Fred […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.